Examples of 'key secondary' in a sentence
Meaning of "key secondary"
key secondary - This phrase refers to something that is important in a supporting role or as a supplementary element to something else. It is often used to highlight the significance of a secondary factor or component
How to use "key secondary" in a sentence
Basic
Advanced
key secondary
A key secondary endpoint is the restoration of haemostasis.
The number of oocytes retrieved was a key secondary efficacy endpoint.
Both key secondary endpoints were also met.
Ertugliflozin also met the key secondary endpoints of the study.
A key secondary endpoint was the restoration of haemostasis.
The study successfully met its primary endpoint and key secondary endpoints.
Primary and key secondary endpoints primary endpoint.
The primary endpoint of the study was overall survival with a key secondary endpoint of PFS.
Key secondary efficacy endpoints.
Results for the primary and key secondary endpoints are summarised in the table below.
Key secondary sources are listed at the end of this report.
Overall Survival was the key secondary study endpoint.
Key secondary objectives.
BPRR operates two key secondary lines.
Key secondary endpoints are planned to include ageappropriate timed function tests.
See also
The primary endpoint of the study was OS with a key secondary endpoint of PFS.
Trial included key secondary and other secondary endpoints.
Furthermore, there was no clinical benefit in key secondary efficacy endpoints.
Key secondary endpoints included time to angiomyolipoma progression and skin lesion response rate.
Legislation needs to be further refined, while key secondary legislation remains to be adopted.
Key secondary and exploratory endpoints with the addition of apalutamide to ADT were also met.
Data from a pre-specified pooled analysis showed improvements in multiple key secondary endpoints.
All other pre-specified key secondary endpoints were met with very high statistical significance.
See Table 6 for a summary of primary and key secondary outcomes.
Key secondary continuous outcome measures will be the ABC-SW.
Data for overall survival, the key secondary endpoint of the trial, are not yet mature.
PFS assessed by blinded independent radiology review ( BIR ) was a key secondary efficacy outcome.
Results for the primary and key secondary endpoints in these studies are described in Table 1.
The C-EARLY trial met its primary and key secondary endpoints.
The key secondary composite endpoint ( ADPKD progression ) was time to multiple clinical progression events of.
Lusutrombopag met the pre-specified primary and all key secondary endpoints with statistically significant results.
Key secondary efficacy outcome measures were investigator-assessed ORR and PFS.
This endpoint was defined as the key secondary efficacy endpoint for Study 1.
Key secondary endpoints included ORR, OS, rate of hematologic improvement and safety.
Results obtained for the primary and key secondary endpoints are provided in Table 2.
Key secondary efficacy outcome measures were investigator-assessed PFS and objective response rate ORR.
The primary endpoint was PFS ; OS was the key secondary endpoint.
The other key secondary endpoint - new onset of diabetes - was neutral.
Overall survival ( OS ) was the key secondary endpoint.
Key secondary outcomes ( responder rate, migraine attack rate, use of rescue medication ) demonstrated a consistent response.
Overall survival ( OS ) was a key secondary study endpoint.
Key secondary efficacy endpoints included overall survival ( OS ) and objective response rate ( ORR ).
Table 5, Rates of composite cardiovascular outcomes and key secondary outcomes.
Key secondary efficacy outcome measures were investigator-assessed objective response rate ( ORR ) and progression-free survival PFS.
Table 14 includes the results for ORR4 and other key secondary endpoints.
A key secondary efficacy endpoint was ORR according to RECIST 1.1 as evaluated by BIRC.
The tocilizumab 8 mg / kg + MTX group also showed statistically significant results across the key secondary endpoints.
A key secondary instrument included the Clinical Global Impression-Bipolar ( CGI-BP ) Scale.
Each study was of 52 weeks duration, with primary and key secondary endpoints at 24 weeks.
A key secondary endpoint was the incidence of proven / probable IFIs at 100 days post-randomization.
You'll also be interested in:
Examples of using Secondary
Show more
No secondary cases were found following this importation
Associated and secondary data centre costs
Secondary information published in the form of reports
Examples of using Key
Show more
Activate the keypad using the key
The key developments may be summarized as follows
Stability is another key element in quality of life
